we published data on 31 BCG-Naïve patients with follow-up for many of them up to 12 months. In that data set, we put up a 72.4% CR at any time at the 6-month time point and 50% CR at 12 months. So what does that mean for our BCG-Unresponsive patients? As I said, we do not believe that a BCG-Unresponsive patient is biologically different from a naïve patient in the context of 002. And so if in February, we have a 72% complete response rate at 6 months and a 50% complete response rate at 12 months in our unresponsive patients, we would, a, be unsurprised; and b, be very happy with that because those numbers in the unresponsive setting are clearly through a threshold of relevance from an efficacy perspective, and that allows us to then talk about 002 in the context of what it means as a product.

2월달에 bcg불응성 데이터 나오고 bcg미투여환자랑 bcg불응성 환자랑 tar002 기전에선 별차이 없다고 봐서
bcg 미투여 환자 데이터랑 비슷하게 나와도 별로 놀랍지 않다 라고함

- dc official App